Growing Role of Regorafenib in the Treatment of Patients with Sarcoma Mark AgulnikSteven Attia Review Article 21 June 2018 Pages: 417 - 422
MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours Michele GhidiniJens C. HahneNicola Valeri Review Article 13 July 2018 Pages: 423 - 436
The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma Xiao LiuJinfeng WuJinhua Xu Review Article 17 April 2018 Pages: 437 - 446
Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-Analysis Zipeng LuMaximilian WenigerJan G. D’Haese Systematic Review 31 July 2018 Pages: 447 - 459
Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis William H. IsacoffHoward A. ReberO. Joe Hines Original Research Article Open access 07 June 2018 Pages: 461 - 468
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24) Alberto FarolfiMicaela PetroneUgo De Giorgi Original Research Article 14 June 2018 Pages: 469 - 479
Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo Xihui WangRui YangDaozhen Chen Original Research Article 10 July 2018 Pages: 481 - 494
Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study Pedro C. BarataPrateek MendirattaJorge A. Garcia Short Communication 04 July 2018 Pages: 495 - 500
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors Karima SaboundjiJean-Bernard AuliacChristos Chouaïd Short Communication 23 July 2018 Pages: 501 - 507
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries Marion FerreiraEric PichonSylvain Marchand-Adam Therapy in Practice 13 July 2018 Pages: 509 - 515
BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review Xuanzong LiShijiang WangLinlin Wang Therapy in Practice 16 June 2018 Pages: 517 - 523
Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia Zaina T. Al-Salama Adis Drug Evaluation 09 August 2018 Pages: 525 - 532
Niraparib: A Review in Ovarian Cancer Young-A HeoSean T. Duggan Adis Drug Evaluation 03 August 2018 Pages: 533 - 539